| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |